1982
DOI: 10.1016/s0190-9622(82)70053-2
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics of the retinoids isotretinoin and etretinate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
34
0
2

Year Published

1984
1984
1994
1994

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 112 publications
(36 citation statements)
references
References 6 publications
0
34
0
2
Order By: Relevance
“…Isotretinoin has a complex me tabolism. as 4-oxo-isotretinoin is its major metabolite and a glucuronized compound is excreted in bile and urine [6]. In our case, temporary acute alcohol consumption in a patient with a past history of chronic alcohol ingestion might have induced hepatic microsomal enzymes transitorily, thus increasing retinoid biotransformation and both decreasing therapeutic efficacy and undesirable secondary effects.…”
mentioning
confidence: 66%
“…Isotretinoin has a complex me tabolism. as 4-oxo-isotretinoin is its major metabolite and a glucuronized compound is excreted in bile and urine [6]. In our case, temporary acute alcohol consumption in a patient with a past history of chronic alcohol ingestion might have induced hepatic microsomal enzymes transitorily, thus increasing retinoid biotransformation and both decreasing therapeutic efficacy and undesirable secondary effects.…”
mentioning
confidence: 66%
“…Less than 1% have presented pyogenic gra nuloma-like lesions and smaller numbers crythcma-multiforme-like lesions [1,2], An unusual side effect of etreti nate was a nodular prurigo-like eruption [3]. Brazzell and Colburn [4] confirm the storing of etretinate in adipose tis sue until its elimination after prolonged treatments. Detec tion of blood traces, even 3 years after ceasing therapy, have been reported [5].…”
Section: Discussionmentioning
confidence: 88%
“…In contrast to 4-hydroxy-retinamide or fenretinide [11,12], retinol and retinol-binding protein have not been markedly altered with increased total plasma retinoic acids until now. Maximum plasma levels occur 1-6 h after oral administration [13,14], with a biphasic mean elimination half-life of 1.3 h for 13-cis-RA and 17 h for 4-oxo-13-cis-RA. Under 13-cis-RA monotherapy, plasma concentrations have remained stable for 25 days [14].…”
Section: Resultsmentioning
confidence: 99%
“…Maximum plasma levels occur 1-6 h after oral administration [13,14], with a biphasic mean elimination half-life of 1.3 h for 13-cis-RA and 17 h for 4-oxo-13-cis-RA. Under 13-cis-RA monotherapy, plasma concentrations have remained stable for 25 days [14]. Due to a short plasma half-life of liarozole, dosedependent retinoid side effects can be controlled easily during combined therapy and have never necessitated any glucocorti coid intervention [15].…”
Section: Resultsmentioning
confidence: 99%